A recent study conducted in South Korea has identified a link between mRNA COVID-19 vaccines and an increased risk of acute heart disease, particularly in younger individuals. Published by Cambridge University, the research titled “The impact of COVID-19 status and vaccine type following the first dose on acute heart disease: A nationwide retrospective cohort study in South Korea” analyzed data from over three million individuals in South Korea, examining the effects of COVID-19 infection and vaccine type on heart health.
The study, authored by researchers Choa Yun, Yaeji Lee, Seok-Jae Heo, Namhui Kim, and Inkyung Jung, specifically investigated the relationship between heart disease risk and mRNA vaccines within 21 days following the first vaccination dose. According to the findings, individuals who received an mRNA vaccine showed a 48% higher risk of developing acute heart conditions such as myocarditis, pericarditis, and cardiac arrhythmia compared to those receiving non-mRNA vaccines.
Moreover, the study revealed that COVID-19 infection itself significantly heightened the risk of acute heart disease. Individuals who had contracted SARS-CoV-2 exhibited a heart disease risk more than three times greater than uninfected individuals. However, no significant interaction was found between vaccine type and COVID-19 infection status, indicating that each factor independently affects heart disease risk.
The research also highlighted age as an important factor in heart disease risk linked to mRNA vaccines. Younger individuals showed a greater susceptibility to vaccine-related cardiac issues than older age groups. “These results may suggest the need to consider alternative vaccine options for the younger population,” the authors noted.
The findings add to ongoing discussions on COVID-19 vaccine safety. Previous research, including studies by Rancourt et al. and Mostert et al., has reported potential health risks associated with COVID-19 vaccinations. Rancourt’s study estimated that 17 million deaths may be attributable to COVID-19 vaccines worldwide as of September 2023, while Mostert and colleagues reported 3.1 million excess deaths tied to vaccination and lockdown policies across 47 Western countries from 2020 to 2022.